Evidence map›Paper›PMID 31305407›Full record

ArticleMedicine2019

Fabry disease and immunoglobulin A nephropathy presenting with Alport syndrome-like findings: A case report.

Hang Ren, Lin Li, Jiyun Yu, Shan Wu, Shanshan Zhou, Yang Zheng, Weixia Sun

Open access · goldAbstract readCase Reports
In one paragraph

Article in Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Elevated Ambulatory Blood Pressure Measurements are Associated with a Progressive Form of Fabry Disease.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2021
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hang RenDepartment of Cardiology.
Lin LiDepartment of Nephrology, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Jiyun YuDepartment of Nephrology, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Shan WuDepartment of Nephrology, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Shanshan ZhouDepartment of Cardiology.
Yang ZhengDepartment of Cardiology.
Weixia SunDepartment of Nephrology, The First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleFabry's disease is an X-linked inherited syndrome. Herein, we presented an unusual case of Fabry disease coexisting with immunoglobulin A nephropathy (IgAN) presenting with Alport syndrome-like pathological findings. PATIENT CONCERNS: We report a 30-year-old male who presented with proteinuria and elevated serum creatinine and for whom the initial pathologic diagnosis supported Alport syndrome. DIAGNOSES: A diagnosis of Fabry disease with immunoglobulin A nephropathy (IgAN) was finally made after further examination.

interventionsAfter the initial diagnosis the patient was treated with herbal medications and mecobalamin. OUTCOMES: The patient was discharged 1 week later. He was maintained on these treatments and received regular follow-up in our hospital. LESSONS SUBSECTIONS AS PER STYLE: FD coexisting with IgAN is rare and may have nonspecific clinical presentations. Laboratory examination and genetic diagnosis is needed for confirmation. Timely diagnosis and reproductive intervention is needed for therapy.

Indexed as

AdultDiagnosis, DifferentialFabry DiseaseHumansImmunoglobulin AKidneyMaleNephritisImmunoglobulin A

Identifiers

PMID31305407
PMCPMC6641842
OpenAlexW2957556250

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.